Blog

NIH Awards $1 Million to Ataxia Research

Thanks NAF Donors for Helping Make It Possible In 2015, Miao Zhang, Ph.D. was early in his career on the Ataxia research scene, but he had a strong desire to look for answers. He applied for a Young Investigator Grant from the National Ataxia Foundation to help get his project Read More…

Print Friendly, PDF & Email

2017 Research Drive Kicks Off

Join the 2017 Research Drive to Help #CureAtaxia The Annual Ataxia Research Drive began on October 15 with the challenge to raise $400,000 by December 15 to fund the finest Ataxia research. There were 84 research applications submitted to the National Ataxia Foundation for consideration. They are currently being peer-reviewed Read More…

Print Friendly, PDF & Email
Clinical Trial News

Ataxia Clinical Trial Progresses to 48-Week Extension Phase

BIOHAVEN¬†OPTIMISTIC FOR NEXT PHASE OF TRIAL DESPITE DISAPPOINTING TOPLINE DATA As NAF previously reported, BioHaven Pharmaceutical Holding Company Ltd. recently completed its 8-week trial of dosing for its drug compound trigriluzole. This is the largest clinical trial for Spinocerebellar Ataxia (SCA) to-date. During the 8-week randomization phase, either the compound Read More…

Print Friendly, PDF & Email

Want to be a guest blogger?

Submit your name and blog topic. We’ll follow up with submission instructions.

Print Friendly, PDF & Email